⭐ Top Story
From Outlaw to Legal: What’s Actually Changing April 28?
FEDERAL REGULATION The Historic Shift: What Schedule III Rescheduling Actually Means After decades of Schedule I classification, the DEA has officially moved state-licensed medical marijuana
📈 Top Movers
Why Cannabis Operators Are Quietly Buying Back Stock
By Sheeba M. | April 27, 2026 Why Cannabis Operators Are Quietly Buying Back Stock TL;DR: With cannabis stocks trading at historically depressed valuations, MSOs
GLP-1 Diet Drugs Are Killing Cannabis Sales (Here’s Why)
By Sheeba M. | April 25, 2026 “GLP-1 Weight Loss Boom Quietly Reshaping the $40B Cannabis Market” TL;DR Dispensaries are adjusting product offerings as GLP-1
Cannabis M&A Isn’t Dead—It’s Just Invisible Now
By Sheeba M. | April 25, 2026 “Why Cannabis M&A in 2026 Will Look Nothing Like Past Deals” TL;DR April 2026 saw 11 cannabis transactions,
📰 Today's News
Cannabis M&A War: Which Operator Becomes the Consolidator?
By Sheeba M. | April 28, 2026 Cannabis M&A War: Which Operator Becomes the Consolidator? TL;DR: Rescheduling valuation boom unlocks M&A math that was broken
Schedule III Rescheduling Unleashes Millions in Tax Savings for MSOs
By Sheeba M. | April 28, 2026 Schedule III Rescheduling Unleashes $Millions in Tax Savings for MSOs TL;DR: Federal Register finalizes cannabis Schedule III move
Federal Banking Access: Why Cannabis Companies Are Winning With Institutions
By Sheeba M. | April 28, 2026 Federal Banking Access: Why Cannabis Companies Are Winning With Institutions TL;DR: Recent progress on federal banking access for
Cannabis Derivatives Market Surge: A $5B Opportunity Emerging
By Sheeba M. | April 28, 2026 Cannabis Derivatives Market Surge: A $5B Opportunity Emerging TL;DR: The cannabis derivatives sector is projected to reach $5
Hemp Derivatives Markets Show Unexpected Volatility in Q2
By Sheeba M. | April 28, 2026 Hemp Derivatives Markets Show Unexpected Volatility in Q2 TL;DR: Delta-8 and THC-O market saturation is driving commodity price
Cannabis Industry M&A Accelerates Post-Rescheduling
By Sheeba M. | April 28, 2026 Cannabis Industry M&A Accelerates Post-Rescheduling TL;DR: Mergers and acquisitions in cannabis are heating up as federal decriminalization creates